These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11552048)

  • 1. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
    Müller TH
    Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
    Chaturvedi S
    Clin Ther; 2008 Jul; 30(7):1196-205. PubMed ID: 18691981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
    Lenz TL; Hilleman DE
    Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects.
    Catella-Lawson F
    Neurology; 2001; 57(5 Suppl 2):S5-7. PubMed ID: 11552047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
    J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats.
    Aldandashi S; Noor R; Wang CX; Uddin G; Shuaib A
    Exp Neurol; 2007 Jun; 205(2):563-8. PubMed ID: 17466978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
    Dalton B; Papoushek C; Evans MF
    Can Fam Physician; 2001 Nov; 47():2235-9. PubMed ID: 11768921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long term effects of 50 mg acetylsalicylic acid alone and in combination with dipyridamole on platelet function after coronary bypass surgery].
    Hoffmann MW; Rauhöft C; Terres W
    Z Kardiol; 1998 Nov; 87(11):865-71. PubMed ID: 9885179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
    Sivenius J; Cunha L; Diener HC; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
    Acta Neurol Scand; 1999 Jan; 99(1):54-60. PubMed ID: 9925239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
    Scheen AJ
    Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release dipyridamole/aspirin.
    Hervey PS; Goa KL
    Drugs; 1999 Sep; 58(3):469-75; discussion 476-7. PubMed ID: 10493274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
    Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
    Valles J; Santos MT; Aznar J; Osa A; Lago A; Cosin J; Sanchez E; Broekman MJ; Marcus AJ
    Circulation; 1998 Feb; 97(4):350-5. PubMed ID: 9468208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis.
    Shah H; Gondek K
    Clin Ther; 2000 Mar; 22(3):362-70; discussion 360-1. PubMed ID: 10963290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.